VEGF Receptor 2 antibody
GTX17530
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
TargetKDR
Overview
- SupplierGeneTex
- Product NameVEGF Receptor 2 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500. IHC: 1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID3791
- Target nameKDR
- Target descriptionkinase insert domain receptor
- Target synonymsCD309, FLK1, VEGFR, VEGFR2, vascular endothelial growth factor receptor 2, fetal liver kinase-1, kinase insert domain receptor (a type III receptor tyrosine kinase), protein-tyrosine kinase receptor Flk-1, soluble VEGFR2, tyrosine kinase growth factor receptor
- HostChicken
- IsotypeIgY
- Protein IDP35968
- Protein NameVascular endothelial growth factor receptor 2
- Scientific DescriptionVEGF receptor 2 is a member of a receptor tyrosine kinase family whose activation plays an essential role in a large number of biological processes such as embryonic development, wound healing, cell proliferation, migration and differentiation. Like other growth factor receptors, upon ligand binding VEGF receptor 2 dimerises and is autophosphorylated on multiple tyrosine residues. These sites can be involved in the regulation of kinase activity or serve as binding sites for SH2 and phosphotyrosine binding containing signalling proteins. Phosphorylation of Tyrosines 1054 and 1059 in the activation loop is required for activation of VEGF receptor 2 and its intrinsic tyrosine kinase activity.
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Allyl isothiocyanate ameliorates angiogenesis and inflammation in dextran sulfate sodium-induced acute colitis. Davaatseren M et al., 2014, PLoS OneRead more
- Proteolytic Activity Attenuates the Response of Endothelial Cells to Fluid Shear Stress. Altshuler AE et al., 2012 Mar, Cell Mol BioengRead more
- Acute venous occlusion enhances matrix metalloprotease activity: Implications on endothelial dysfunction. Alsaigh T et al., 2011 Jan, Microvasc ResRead more


![Activation assay analysis of HUVECs pre-treated with 5.0 and 25 microg/ml GTX53462 VEGF Receptor 2 antibody [6B11] and then stimulated with rhVEGF (10ng/ml) for 30min. The phospho-VEGFR2 was detected by detected with IP-Western for P-Tyrosine.](https://www.genetex.com/upload/website/prouct_img/normal/GTX53462/GTX53462_20191119_Activation_w_23060900_230.webp)
![Activation assay analysis of HUVECs stimulated with 20ng/ml VEGF or treated with 5.0 and 25 microg/ml GTX53464 VEGF Receptor 2 antibody [8A01] (30mins). Phospho-VEGFR2 was detected with IP-Western for P-Tyrosine.](https://www.genetex.com/upload/website/prouct_img/normal/GTX53464/GTX53464_20191119_Activation_w_23060900_578.webp)
![FACS analysis of HepG2 cells using GTX83308 VEGF Receptor 2 antibody [4B4]. Green : VEGF Receptor 2 Purple : negative control](https://www.genetex.com/upload/website/prouct_img/normal/GTX83308/GTX83308_20170912_FACS_w_23061322_153.webp)


